• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EVE
Click for more information
0.00% 0.1¢

EVE HEALTH GROUP LIMITED. - Announcements

Market Cap $5.274M  ! watchlist Created with Sketch. Add to my watchlist

EVE Health Group Limited is an Australia-based vertically integrated producer of branded... EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Company’s Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
EVE Eagle Commences Production of Omni's Pre-Meal Diabetes ShakePRICE SENSITIVE31/10/17
EVE Appendix 4C - QuarterlyPRICE SENSITIVE20/10/17
EVE Notice of Annual General Meeting/Proxy Form20/10/17
EVE Appendix 4G and Corporate Governance Statement20/10/17
EVE Annual Report to Shareholders20/10/17
EVE Replacement Appendix 3B18/10/17
EVE Initial Director's Interest Notice16/10/17
EVE Appendix 3B13/10/17
EVE ProspectusPRICE SENSITIVE13/10/17
EVE Net Tangible Asset Backing10/10/17
EVE Reinstatement to Official QuotationPRICE SENSITIVE06/10/17
EVE $1.2m Capital RaisingPRICE SENSITIVE06/10/17
EVE Update on Capital Raising02/10/17
EVE Voluntary SuspensionPRICE SENSITIVE27/09/17
EVE Trading HaltPRICE SENSITIVE25/09/17
EVE Omni Innovation Executes Chinese Licence Agreement22/09/17
EVE Net Tangible Asset Backing20/09/17
EVE Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE01/09/17
EVE Revised Medical Honey Investment StructurePRICE SENSITIVE28/08/17
EVE Omni Innovation Enters Chinese Distribution AgreementPRICE SENSITIVE16/08/17
EVE Net Tangible Asset Backing14/08/17
EVE Trading HaltPRICE SENSITIVE14/08/17
EVE Appendix 4C - QuarterlyPRICE SENSITIVE31/07/17
EVE Net Tangible Asset Backing14/07/17
EVE Change of Director's Interest Notice x 305/07/17
EVE Appendix 3B04/07/17
EVE ProspectusPRICE SENSITIVE04/07/17
EVE Results of Meeting26/06/17
EVE Accelerating Portfolio ProgressPRICE SENSITIVE26/06/17
EVE Net Tangible Asset Backing14/06/17
EVE Investor Presentation31/05/17
EVE Southern Cross University Collaboration with Medic HoneyPRICE SENSITIVE30/05/17
EVE Notice of General Meeting/Proxy Form25/05/17
EVE Appointment of Leading Medicinal Cannabis Advisor18/05/17
EVE Net Tangible Asset Backing12/05/17
EVE Change in Substantial Holding09/05/17
EVE Change of Director's Interest Notice x 309/05/17
EVE Replacement Appendix 3B09/05/17
EVE EVE Capital Raising Completed05/05/17
EVE Appendix 3B05/05/17
EVE ProspectusPRICE SENSITIVE05/05/17
EVE EVE Capital Raising Oversubscribed03/05/17
EVE Reinstatement to Official QuotationPRICE SENSITIVE02/05/17
EVE Eve Invests in Pioneering Cannabis Honey & Tea Tree Oil Co01/05/17
EVE Appendix 4C - Quarterly28/04/17
EVE LNK: Change of Perth Address for Shareholder Purposes21/04/17
EVE Update on Capital Raising21/04/17
EVE Update on Capital Raising18/04/17
EVE Net Tangible Asset Backing13/04/17
EVE Update on Capital Raising10/04/17
EVE Update on Capital Raising03/04/17
EVE Voluntary SuspensionPRICE SENSITIVE27/03/17
EVE Trading HaltPRICE SENSITIVE23/03/17
EVE Omni Innovation - US Manufacturer Appointed23/03/17
EVE Omni Innovation Completes UK Licence Agreement22/03/17
EVE Net Tangible Asset Backing14/03/17
EVE Omni Innovation US Update08/03/17
EVE Omni Innovation - US Patent Notice of Allowance ReceivedPRICE SENSITIVE01/03/17
EVE Omni Innovation Update28/02/17
EVE Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
EVE Results of Meeting14/02/17
EVE Net Tangible Asset Backing13/02/17
EVE Appendix 4C - QuarterlyPRICE SENSITIVE30/01/17
EVE Sales Results Exceed Expectations for Faulding GlucoControlPRICE SENSITIVE25/01/17
EVE Change of Director's Interest Notice17/01/17
EVE Notice of General Meeting/Proxy Form12/01/17
EVE Change in Substantial Holding11/01/17
EVE Net Tangible Asset Backing11/01/17
EVE Update on Omni Innovation Investment30/12/16
EVE RGP: Refresh Invests in Technology CompanyPRICE SENSITIVE28/12/16
EVE Appendix 3B23/12/16
EVE ProspectusPRICE SENSITIVE23/12/16
EVE Reinstatement to Official QuotationPRICE SENSITIVE23/12/16
EVE $1.6m Placement for Omni Innovation InvestmentPRICE SENSITIVE23/12/16
EVE Net Tangible Asset Backing22/12/16
EVE Withdrawal of Entitlement Issue14/12/16
EVE Suspension from Official QuotationPRICE SENSITIVE14/12/16
EVE Trading HaltPRICE SENSITIVE12/12/16
EVE Notification of Rights Issue ShortfallPRICE SENSITIVE09/12/16
EVE Omni Innovation Market UpdatePRICE SENSITIVE02/12/16
EVE Rights Issue Offer Document25/11/16
EVE Results of Meeting22/11/16
EVE Becoming a Substantial Holder22/11/16
EVE Omni Innovation secures UK Distribution DealPRICE SENSITIVE21/11/16
EVE Letter to Shareholders18/11/16
EVE Letter to Optionholders16/11/16
EVE Appendix 3B and Cleansing Notice16/11/16
EVE Non-Renounceable Rights OfferPRICE SENSITIVE16/11/16
EVE Appendix 3B16/11/16
EVE Net Tangible Asset Backing14/11/16
EVE Reinstatement to Official QuotationPRICE SENSITIVE10/11/16
EVE Placement to Chinese Pharmaceutical and Investment GroupPRICE SENSITIVE10/11/16
EVE Voluntary Suspension-EVE.AX PRICE SENSITIVE03/11/16
EVE Voluntary SuspensionPRICE SENSITIVE03/11/16
EVE Trading Halt-EVE.AX PRICE SENSITIVE01/11/16
EVE Appendix 4C - Quarterly-EVE.AX PRICE SENSITIVE01/11/16
EVE Notice of Annual General Meeting/Proxy Form-EVE.AX 21/10/16
EVE Appendix 4G and Corporate Governance Statement-EVE.AX 21/10/16
EVE Annual Report to Shareholders-EVE.AX 21/10/16
EVE Net Tangible Asset Backing-EVE.AX 14/10/16
EVE Eagle Commences Production of Omni's Pre-Meal Diabetes Shake
31/10/17PRICE SENSITIVE
EVE Appendix 4C - Quarterly
20/10/17PRICE SENSITIVE
EVE Notice of Annual General Meeting/Proxy Form
20/10/17
EVE Appendix 4G and Corporate Governance Statement
20/10/17
EVE Annual Report to Shareholders
20/10/17
EVE Replacement Appendix 3B
18/10/17
EVE Initial Director's Interest Notice
16/10/17
EVE Appendix 3B
13/10/17
EVE Prospectus
13/10/17PRICE SENSITIVE
EVE Net Tangible Asset Backing
10/10/17
EVE Reinstatement to Official Quotation
06/10/17PRICE SENSITIVE
EVE $1.2m Capital Raising
06/10/17PRICE SENSITIVE
EVE Update on Capital Raising
02/10/17
EVE Voluntary Suspension
27/09/17PRICE SENSITIVE
EVE Trading Halt
25/09/17PRICE SENSITIVE
EVE Omni Innovation Executes Chinese Licence Agreement
22/09/17
EVE Net Tangible Asset Backing
20/09/17
EVE Appendix 4E and Full Year Statutory Accounts
01/09/17PRICE SENSITIVE
EVE Revised Medical Honey Investment Structure
28/08/17PRICE SENSITIVE
EVE Omni Innovation Enters Chinese Distribution Agreement
16/08/17PRICE SENSITIVE
EVE Net Tangible Asset Backing
14/08/17
EVE Trading Halt
14/08/17PRICE SENSITIVE
EVE Appendix 4C - Quarterly
31/07/17PRICE SENSITIVE
EVE Net Tangible Asset Backing
14/07/17
EVE Change of Director's Interest Notice x 3
05/07/17
EVE Appendix 3B
04/07/17
EVE Prospectus
04/07/17PRICE SENSITIVE
EVE Results of Meeting
26/06/17
EVE Accelerating Portfolio Progress
26/06/17PRICE SENSITIVE
EVE Net Tangible Asset Backing
14/06/17
EVE Investor Presentation
31/05/17
EVE Southern Cross University Collaboration with Medic Honey
30/05/17PRICE SENSITIVE
EVE Notice of General Meeting/Proxy Form
25/05/17
EVE Appointment of Leading Medicinal Cannabis Advisor
18/05/17
EVE Net Tangible Asset Backing
12/05/17
EVE Change in Substantial Holding
09/05/17
EVE Change of Director's Interest Notice x 3
09/05/17
EVE Replacement Appendix 3B
09/05/17
EVE EVE Capital Raising Completed
05/05/17
EVE Appendix 3B
05/05/17
EVE Prospectus
05/05/17PRICE SENSITIVE
EVE EVE Capital Raising Oversubscribed
03/05/17
EVE Reinstatement to Official Quotation
02/05/17PRICE SENSITIVE
EVE Eve Invests in Pioneering Cannabis Honey & Tea Tree Oil Co
01/05/17
EVE Appendix 4C - Quarterly
28/04/17
EVE LNK: Change of Perth Address for Shareholder Purposes
21/04/17
EVE Update on Capital Raising
21/04/17
EVE Update on Capital Raising
18/04/17
EVE Net Tangible Asset Backing
13/04/17
EVE Update on Capital Raising
10/04/17
EVE Update on Capital Raising
03/04/17
EVE Voluntary Suspension
27/03/17PRICE SENSITIVE
EVE Trading Halt
23/03/17PRICE SENSITIVE
EVE Omni Innovation - US Manufacturer Appointed
23/03/17
EVE Omni Innovation Completes UK Licence Agreement
22/03/17
EVE Net Tangible Asset Backing
14/03/17
EVE Omni Innovation US Update
08/03/17
EVE Omni Innovation - US Patent Notice of Allowance Received
01/03/17PRICE SENSITIVE
EVE Omni Innovation Update
28/02/17
EVE Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
EVE Results of Meeting
14/02/17
EVE Net Tangible Asset Backing
13/02/17
EVE Appendix 4C - Quarterly
30/01/17PRICE SENSITIVE
EVE Sales Results Exceed Expectations for Faulding GlucoControl
25/01/17PRICE SENSITIVE
EVE Change of Director's Interest Notice
17/01/17
EVE Notice of General Meeting/Proxy Form
12/01/17
EVE Change in Substantial Holding
11/01/17
EVE Net Tangible Asset Backing
11/01/17
EVE Update on Omni Innovation Investment
30/12/16
EVE RGP: Refresh Invests in Technology Company
28/12/16PRICE SENSITIVE
EVE Appendix 3B
23/12/16
EVE Prospectus
23/12/16PRICE SENSITIVE
EVE Reinstatement to Official Quotation
23/12/16PRICE SENSITIVE
EVE $1.6m Placement for Omni Innovation Investment
23/12/16PRICE SENSITIVE
EVE Net Tangible Asset Backing
22/12/16
EVE Withdrawal of Entitlement Issue
14/12/16
EVE Suspension from Official Quotation
14/12/16PRICE SENSITIVE
EVE Trading Halt
12/12/16PRICE SENSITIVE
EVE Notification of Rights Issue Shortfall
09/12/16PRICE SENSITIVE
EVE Omni Innovation Market Update
02/12/16PRICE SENSITIVE
EVE Rights Issue Offer Document
25/11/16
EVE Results of Meeting
22/11/16
EVE Becoming a Substantial Holder
22/11/16
EVE Omni Innovation secures UK Distribution Deal
21/11/16PRICE SENSITIVE
EVE Letter to Shareholders
18/11/16
EVE Letter to Optionholders
16/11/16
EVE Appendix 3B and Cleansing Notice
16/11/16
EVE Non-Renounceable Rights Offer
16/11/16PRICE SENSITIVE
EVE Appendix 3B
16/11/16
EVE Net Tangible Asset Backing
14/11/16
EVE Reinstatement to Official Quotation
10/11/16PRICE SENSITIVE
EVE Placement to Chinese Pharmaceutical and Investment Group
10/11/16PRICE SENSITIVE
EVE Voluntary Suspension-EVE.AX
03/11/16PRICE SENSITIVE
EVE Voluntary Suspension
03/11/16PRICE SENSITIVE
EVE Trading Halt-EVE.AX
01/11/16PRICE SENSITIVE
EVE Appendix 4C - Quarterly-EVE.AX
01/11/16PRICE SENSITIVE
EVE Notice of Annual General Meeting/Proxy Form-EVE.AX
21/10/16
EVE Appendix 4G and Corporate Governance Statement-EVE.AX
21/10/16
EVE Annual Report to Shareholders-EVE.AX
21/10/16
EVE Net Tangible Asset Backing-EVE.AX
14/10/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.274M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
EVE (ASX) Chart

Top Stories

Sales growth pushes Lovisa's fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.